Close

Analyst Ratings for Medicenna Therapeutics (MDNA) [Buys]

MDNA Rating Summary

  |   Expand Research on MDNA
Overall Rating: BUY   Rating Trend: =   Avg. $ Target: N/A
Rating Score: 10 / 10
Date Firm Analyst Type Rating
(Past)
PT
(Past)
Start $
(End $)
% Chg. Details
12/18/2020 Oppenheimer
» Updated 8/10/2022
Matthew Biegler New Coverage Outperform
(N/A)
8.00
(10.00)
3.82
(0.16)
-95.81% Details